On-Demand Webinar: Complex, 3D Screening for Cancer Immunotherapy

Screening for potential anti-cancer immunotherapies benefits from 3D platforms to detect complex, multi-cell and multi-step effects on the immune system. Watch this on-demand webinar to learn: Differences between 2D and 3D drug screening models How 3D cultures can mimic cancer cell-immune cell interactions How to maximize reproducibility in a 3D drug screening assay Who Should […]

Read More…

The CDNR Platform – Progressing the Promise of Personalized Medicine

CDNR Novaseek Research Science Exchange

Most everyone knows that precision medicine promises to transform the healthcare landscape, delivering powerful and personalized treatments for previously intractable diseases. Even so, biotech innovators still face tremendous hurdles in realizing this promise — chief among them, finding access to sufficient numbers of annotated, characterized and consented patient samples. Novaseek Research has developed a unique […]

Read More…

Take 5 – The Future of Now — How the Science of Today Shapes Tomorrow

Scientific research is advancing without pause; innovations are emerging at a breathtaking rate all over the world through the endeavors of diverse scientific disciplines. The future of scientific research is set on an unpredictable course teeming with both excitement and unease — whether AI-enabled tools will reshape drug discovery or if “patient-on-a-chip” technology will let […]

Read More…

Science Exchange Announces Outsourced R&D Partnership with Alector

partnership

  PALO ALTO, Calif.–Science Exchange, the world’s leading and most secure enterprise platform and aggregator for outsourced research and development (R&D), today announced a strategic partnership with Alector, a biotech company pioneering the discovery & development of immuno-neurology therapies for neurodegenerative disorders, to provide the company’s scientists access to a private R&D marketplace to accelerate […]

Read More…

QB3 Signs Partnership with Science Exchange

partnership

Bay Area Life Science Hub Enables its Startups to Stay Lean with Science Exchange’s R&D Platform PALO ALTO, CA, October 23, 2017 – Science Exchange, a platform for outsourced research and development (R&D) services, today announced a partnership with QB3, the University of California hub for innovation and entrepreneurship for life sciences. Through an exclusive […]

Read More…

The Robotic Cloud Laboratory for the Life Sciences: Transcriptic

By Natalie Foote, Director of Service Provider Operations, Science Exchange | blog.scienceexchange.com In this Provider Innovation Profile, we’re proud to feature Transcriptic, whose automated cellular and molecular biology platform enables scalable life science research with flexibility and precision. Automation is a rapidly advancing area of biotechnology, and Science Exchange hopes to give our researchers access […]

Read More…

New Providers on Science Exchange: Predictive Models and Analytical Tools for Translational Research

translational-research

If you aren’t exploring the latest cell culture models of human tissue for nonclinical and preclinical testing, you should be. That’s the bottom line of today’s Science Exchange service provider roundup — three of the five newest service providers on our platform are experts in developing predictive models. Advances in predictive model systems Axiogenesis, based […]

Read More…

Alzheimer’s Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS

alzheimers

New “CRO Finder” Connects Scientists with Specialized Resources by Cliff Culver, VP Strategy and GM, Science Exchange | blog.scienceexchange.com NEW YORK, June 7, 2017 — The Alzheimer’s Drug Discovery Foundation (ADDF), the only public charity solely focused on funding the development of drugs for Alzheimer’s, and Science Exchange today announced the launch of ADDF ACCESS, […]

Read More…

Q&A with Barry Bunin, CEO of Collaborative Drug Discovery

drug-discovery

The following is an interview conducted by Science Exchange with Barry Bunin, CEO of Collaborative Drug Discovery (CDD). You can find more info on CDD at: https://www.collaborativedrug.com/ Q: What prompted you to create CDD? A: First we saw a need to broadly empower scientists with self-explanatory technologies for scientific data and decision management.   I especially noticed in […]

Read More…